Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Change in Accured Expenses (2019 - 2025)

Historic Change in Accured Expenses for InfuSystem Holdings (INFU) over the last 11 years, with Q3 2025 value amounting to $1.8 million.

  • InfuSystem Holdings' Change in Accured Expenses fell 952.85% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $420000.0, marking a year-over-year decrease of 7152.54%. This contributed to the annual value of -$676000.0 for FY2024, which is 12799.17% down from last year.
  • InfuSystem Holdings' Change in Accured Expenses amounted to $1.8 million in Q3 2025, which was down 952.85% from -$398000.0 recorded in Q2 2025.
  • InfuSystem Holdings' 5-year Change in Accured Expenses high stood at $2.7 million for Q4 2023, and its period low was -$2.9 million during Q1 2021.
  • In the last 5 years, InfuSystem Holdings' Change in Accured Expenses had a median value of $553000.0 in 2024 and averaged $115000.0.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 115747.13% in 2021, then plummeted by 45335.46% in 2024.
  • InfuSystem Holdings' Change in Accured Expenses (Quarter) stood at -$1.8 million in 2021, then surged by 194.16% to $1.7 million in 2022, then skyrocketed by 55.22% to $2.7 million in 2023, then crashed by 79.55% to $553000.0 in 2024, then surged by 233.09% to $1.8 million in 2025.
  • Its Change in Accured Expenses was $1.8 million in Q3 2025, compared to -$398000.0 in Q2 2025 and -$1.6 million in Q1 2025.